Overview
Financials
Revenue history
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 259 days late).
- 202510/06/2026
- 202414/04/2025
- 202314/04/2024
- 202231/03/2023
- 202131/03/2023
- 202024/08/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the management board represents the company in such a way that: - the President of the Management Board may make declarations on behalf of the company together with a member of the management board or a commercial proxy, - a member of the management board must, when representing the company, act jointly with the President of the Management Board or a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100 | $1,350.62 | 100% |
Beneficial owners
No beneficial owners recorded for the company Public Profits B + R.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ogólnopolski Panel Badawczysp. z o.o. | $1,737,224.54 | panelariadna.pl | ||
| Wiserabbitsp. z o.o. | $1,363,268.00 | wiserabbit.co | ||
| Centrum Badań Marketingowych Indicatorsp. z o.o. | $1,269,397.82 | indicator.pl | ||
| Openfieldsp. z o.o. | $709,346.30 | openfield.pl | ||
| Stratosfera Consultingsp. z o.o. | $356,518.01 | stratosfera.com | ||
| Grupa Badawcza Dscsp. z o.o. | $158,430.19 | grupa-dsc.eu | ||
| TRY Evidencesp. z o.o. | $147,618.64 | tryevidence.com | ||
| QGO Groupsp. z o.o. | $66,598.64 | qgo.pl | ||
| Satisfacesp. z o.o. | $53,960.56 | satisface.pl | ||
| Pharma Bridge Polskasp. z o.o. | – | pharmabridge.pl |
FAQ
Last updated: 2026-10-07